| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 55 |
| 1 | INTERFERON BETA-1A | 45 |
| 2 | FLUOXETINE HYDROCHLORIDE | 29 |
| 3 | DIMETHYL FUMARATE | 27 |
| 4 | AZATHIOPRINE | 26 |
| 5 | NIFEDIPINE | 25 |
| 6 | METHYLDOPA | 24 |
| 7 | ASPIRIN | 23 |
| 8 | ASPIRIN 325 MG | 21 |
| 9 | ASPIRIN 81 MG | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE | 4 | 0.0105 |
| 1 | METHYLDOPA | 24 | 0.0049 |
| 2 | ASCIMINIB | 4 | 0.0011 |
| 3 | LOXAPINE | 4 | 0.0010 |
| 4 | PHYTONADIONE | 7 | 0.0008 |
| 5 | PEGINTERFERON BETA-1A | 9 | 0.0007 |
| 6 | NIFEDIPINE | 25 | 0.0006 |
| 7 | MYCOPHENILIC ACID | 12 | 0.0006 |
| 8 | URSOSIOL | 11 | 0.0006 |
| 9 | URSODIOL | 11 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 56 |
| 1 | Interferon beta [EPC] | 54 |
| 2 | Corticosteroid [EPC] | 40 |
| 3 | Benzodiazepine [EPC] | 35 |
| 4 | Atypical Antipsychotic [EPC] | 32 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 28 |
| 7 | Purine Antimetabolite [EPC] | 26 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 9 | Proton Pump Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Vitamin K [EPC] | 7 | 0.0008 |
| 2 | Oxytocic [EPC] | 2 | 0.0007 |
| 3 | Integrin Receptor Antagonist [EPC] | 56 | 0.0006 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 12 | 0.0006 |
| 6 | Bile Acid [EPC] | 11 | 0.0005 |
| 7 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 8 | Progesterone [EPC] | 8 | 0.0003 |
| 9 | Interferon beta [EPC] | 54 | 0.0003 |